F: 20 Years of Th17 Cells: Discovery and Clinical Impact  

F: 20 Years of Th17 Cells: Discovery and Clinical Impact  

Saturday, April 18, 2026
8:00–11:15 AM
Ballroom 

MAJOR SYMPOSIUM F 

20 Years of Th17 Cells: Discovery and Clinical Impact  

Chairs: 

Sarah L. Gaffen, Univ. of Pittsburgh, USA 

Vijay K. Kuchroo, Gene Lay Inst. of Immunol. and Inflammation, USA 

Speakers: 

Vijay K. Kuchroo, Gene Lay Inst. of Immunol. and Inflammation, USA, Introduction

Daniel Cua, Johnson & Johnson, IL-23 regulation of Th17 immune pathway in autoimmune inflammation 

Mandy J. McGeachy, Cornell Univ., USA, Th17 influencers 

Dan R. Littman, HHMI, NYU Sch. of Med., USA, The immune cellular network defined by ROR𝛾t 

Shreya Das, Albany Med. Col., USA, Dietary iron overload rewires regulatory T cells into IL-17-mediated proinflammatory effectors aggravating Yersinia enterocolitica infection 

Sarah L. Gaffen, Univ. of Pittsburgh, USA, At the crossroads of IL-17 signaling: IL-17 signal transduction in autoimmunity and fungal infections 

Alice Emma Taliento, Massachusetts Gen. Hosp., USA, A unique subset of allergen specific T helper 2+17 tissue resident memory cells is established in a mouse model of allergic inflammation 

Jun R. Huh, Harvard Med. Sch., USA, Unexpected roles of interleukin‑17 and identification of its target cells